comparemela.com

Latest Breaking News On - Sino biopharmaceutical - Page 11 : comparemela.com

Akeso Reported 2022 Annual Results

Strong sales fully demonstrated Akeso s commercialization ability: Products sales totaled RMB1,104.4 million, increasing 422% .开坦尼® (cadonilimab) recorded.

F-star Therapeutics Shares Rally After Cfius Clears Takeover

F-star Therapeutics Shares Rally After Cfius Clears Takeover
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

China 2022 National Reimbursement Drug List Drug Pricing

China National Healthcare Security Administration NHSA published 2022 National Reimbursement Drug List 2022 NRDL, implementing comparable level of pricing discounts to those seen in 2021. Out of 147 drugs negotiated, 121 were successfully added to 2022 NRDL, including 91 exclusive.

F-Star Therapeutics Inc (FSTX) Reports Amendment No 6 to Merger Agreement with invoX Pharma Extending End Date

F-Star Therapeutics Inc (FSTX) Reports Amendment No 6 to Merger Agreement with invoX Pharma Extending End Date
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Form SC TO-T/A F-star Therapeutics, Filed by: Invox Pharma Ltd

Form SC TO-T/A F-star Therapeutics, Filed by: Invox Pharma Ltd
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.